SIBO 진단 시장은 2020년 138,324.23천 달러였으며 2028년에는 194,604.51천 달러에 이를 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 4.4%로 성장할 것으로 예상됩니다.
소장 세균 과증식(SIBO)은 일반적으로 하나 이상의 소인이 있는 상태에서 나타납니다. 그것은 환자와 유기체의 근본적인 장애와 미생물 특성에 따라 크게 다릅니다. SIBO는 무증상일 수 있는 위장관 IBS 유사 증상을 유발합니다. 더 나쁜 경우에는 실제 흡수 장애 증후군이 발생할 수 있습니다. SIBO의 존재는 일반적으로 락툴로오스 수소 및 포도당 호흡 검사로 진단됩니다. 이러한 테스트는 저렴한 비용, 비침습적, 충분한 정확도 및 재현성으로 인해 모든 임상 환경에서 널리 수행됩니다.
SIBO 진단 시장은 진단, 유형 및 지역을 기준으로 분류됩니다. 지리를 기반으로 시장은 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미로 분류됩니다. 이 보고서는 시장 동향, 기술 발전, 시장 역학 및 전 세계 주요 시장 참가자의 경쟁 구도 분석과 같은 다양한 매개 변수를 강조하는 SIBO 진단 시장에 대한 통찰력과 심층 분석을 제공합니다. 또한 모든 지역에 대한 COVID-19 영향 분석도 포함됩니다. COVID-19 대유행으로 인한 제한된 의료 서비스 및 폐쇄 상황으로 인해 예측 기간 동안 시장의 성장률이 느려질 것으로 추정됩니다.
SIBO 진단 시장의 수익성 있는 지역
시장 통찰력
과민성 대장 증후군(IBS) 및 SIBO의 유병률 증가
p>
과민성대장증후군(irritable IBS의 발병률은 전 세계적으로 상당한 비율로 증가하고 있습니다. 2021년 Elsevier Inc.에서 발표한 연구 기사 '기능성 위장 장애의 전 세계 유병률 및 부담, 로마 재단 글로벌 연구 결과'에 따르면 대부분의 국가에서 유병률이 2~6%입니다. 일본, 중국, 러시아, 남아공, 미국 등의 국가는 유병률이 각각 2.2%, 2.3%, 5.9%, 5.9%, 5.3%이다. 전 세계적으로 IBS의 유병률이 증가하는 것은 변화하는 생활 방식과 식습관 때문입니다. 소장 세균 과증식(SIBO)은 IBS와 광범위하게 연관되어 있습니다.
마찬가지로 SIBO는 IBS와 유사한 증상을 나타냅니다. 기술 발전으로 이제 IBS를 진단하면서 SIBO도 진단할 수 있게 되었습니다. 따라서 SIBO의 유병률은 전 세계적으로 널리 이해되고 보고됩니다. 예를 들어, 2015년 11월 JPCRR(Journal of Patient-Centered Research and Reviews)에 게재된 '소장 세균 과증식: 사례 기반 검토(Small Intestinal Bacterial Overgrowth: A Case-Based Review)' 기사에 따르면 성인 IBS 환자의 30~85%가 SIBO를 개발합니다. 마찬가지로 American College of Gastroenterology에서 2020년에 발표한 최근 데이터에 따르면 IBS 환자의 ~78%가 SBIO를 앓고 있습니다. 따라서 주로 평가되는 조건입니다. 따라서 가까운 장래에 IBS 및 SIBO의 유병률이 크게 증가하여 진단 증가 및 궁극적인 시장 성장으로 이어질 것으로 예상됩니다.
진단 기반 통찰력
기반 진단시 SIBO 진단 시장은 호흡 검사, 소장 흡인 및 체액 배양 검사, 혈액 검사 등으로 분류됩니다. 2020년에는 호흡 테스트 부문이 시장에서 가장 큰 점유율을 차지했으며 향후 몇 년 동안 가장 빠른 속도로 성장할 것으로 예상됩니다. 이러한 성장은 비침습성, 환자 친화적, 단순성 및 저비용과 같은 이점 때문입니다. >
유형 기반 통찰력
SIBO 진단 시장은 유형에 따라 수소가 우세한 SIBO, 메탄이 우세한 SIBO 및 재발성 SIBO로 분류됩니다. 2020년에는 수소가 우세한 SIBO 부문이 시장에서 가장 큰 점유율을 차지했으며 동일한 부문이 향후 몇 년 동안 가장 빠른 속도로 성장할 것으로 예상됩니다.
전략적 통찰력
제품 출시와 같은 유기적 전략은 변화하는 고객 수요를 충족하고 개선된 서비스를 유지하기 위해 시장 참여자가 일반적으로 채택합니다. 예를 들어, 2020년 2월 CDI(Commonwealth Diagnostics International), Inc.는 설사 우세형 및 혼합형 과민성 대장 증후군(IBS-D, IBS -M) 새로운 재택 모세혈관 수집 키트.
진단을 통해
- 호흡 검사
- 14C 자일로스 호흡 검사
- 수소 호흡 검사
- 14C 글리코콜산 호흡 검사
- 흡수 장애 검사
- 소장 흡인 및 체액 배양 검사
- 혈액 검사
- 기타
유형별
- 수소가 주를 이루는 SIBO
- 메탄- 주요 SIBO
- 재발 SIBO
지역별
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 프랑스
- 독일
- 이탈리아
- 영국
- 스페인
- 기타 유럽
li>
- 아시아 태평양(APAC)
- 중국
- 인도
- 한국
- 일본
- 호주
- 기타 APAC
- 중동 및 아프리카(MEA)
- 남아프리카
- 사우디아라비아
- UAE
- 기타 MEA
- 중남미(SCAM)
- 브라질
- 아르헨티나
- 나머지 SCAM
li>
회사 프로필
- 제노바 진단
- SIBO 진단
- Commonwealth Diagnostics International
- Aerodiagnostics, LLC
- SIBOTest
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- DirectLabs, LLC< /li>
- 활기찬 웰빙
- Health Associates Medical Group
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Small intestinal bacterial growth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. The presence of SIBO is generally diagnosed with hydrogen lactulose and glucose breath tests. These tests are widely performed in every clinical setting due to their low costs, non-invasively, sufficient accuracy, and reproducibility.
Key factors that are driving growth of the market are increasing incidence of IBS and SIBO and advantages offered by breath tests. However, limitation of diagnostics is a key factor restraining the market growth.
The cost is based on the type of diagnostics test. For instance, the hydrogen breath test is much cheaper than any other test. The cost of the test ranges from US$ 145–US$ 400. Likewise, the cost of endoscopy is ~US$ 135.
The List of Companies - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
- Genova Diagnostics
- SIBO Diagnostics
- Commonwealth Diagnostics International
- Aerodiagnostics, LLC
- SIBOTest
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- DirectLabs, LLC
- Vibrant Wellness
- Health Associates Medical Group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)